Global NGS Tumor Gene Analysis Software Market Growth (Status and Outlook) 2026-2032
The global NGS Tumor Gene Analysis Software market size is predicted to grow from US$ 2313 million in 2025 to US$ 7285 million in 2032; it is expected to grow at a CAGR of 18.2% from 2026 to 2032.
NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.
United States market for NGS Tumor Gene Analysis Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for NGS Tumor Gene Analysis Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for NGS Tumor Gene Analysis Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key NGS Tumor Gene Analysis Software players cover Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?NGS Tumor Gene Analysis Software Industry Forecast? looks at past sales and reviews total world NGS Tumor Gene Analysis Software sales in 2025, providing a comprehensive analysis by region and market sector of projected NGS Tumor Gene Analysis Software sales for 2026 through 2032. With NGS Tumor Gene Analysis Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NGS Tumor Gene Analysis Software industry.
This Insight Report provides a comprehensive analysis of the global NGS Tumor Gene Analysis Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NGS Tumor Gene Analysis Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global NGS Tumor Gene Analysis Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NGS Tumor Gene Analysis Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NGS Tumor Gene Analysis Software.
This report presents a comprehensive overview, market shares, and growth opportunities of NGS Tumor Gene Analysis Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.
United States market for NGS Tumor Gene Analysis Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for NGS Tumor Gene Analysis Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for NGS Tumor Gene Analysis Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key NGS Tumor Gene Analysis Software players cover Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?NGS Tumor Gene Analysis Software Industry Forecast? looks at past sales and reviews total world NGS Tumor Gene Analysis Software sales in 2025, providing a comprehensive analysis by region and market sector of projected NGS Tumor Gene Analysis Software sales for 2026 through 2032. With NGS Tumor Gene Analysis Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NGS Tumor Gene Analysis Software industry.
This Insight Report provides a comprehensive analysis of the global NGS Tumor Gene Analysis Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NGS Tumor Gene Analysis Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global NGS Tumor Gene Analysis Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NGS Tumor Gene Analysis Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NGS Tumor Gene Analysis Software.
This report presents a comprehensive overview, market shares, and growth opportunities of NGS Tumor Gene Analysis Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Non-Small Cell Lung Cancer
- Human 6 Gene Mutations
- Human 12 Gene Mutations
- Other
- Hospitals and Health Systems
- Research Institute
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Illumina
- Thermo Fisher Scientific
- BGI Group
- Novogene
- Geneseeq
- AmoyDx
- Burning Rock Medicine
- GTH.O
- Golden Helix, Inc
- Diatech Pharmacogenetics
- ViennaLab Diagnostics GmbH
- 3D Medicines
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NGS Tumor Gene Analysis Software Market Size (2021-2032)
2.1.2 NGS Tumor Gene Analysis Software Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for NGS Tumor Gene Analysis Software by Country/Region (2021, 2025 & 2032)
2.2 NGS Tumor Gene Analysis Software Segment by Type
2.2.1 Non-Small Cell Lung Cancer
2.2.2 Human 6 Gene Mutations
2.2.3 Human 12 Gene Mutations
2.2.4 Other
2.2.5 NGS Tumor Gene Analysis Software Market Size by Type
2.2.5.1 NGS Tumor Gene Analysis Software Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
2.3 NGS Tumor Gene Analysis Software Segment by Application
2.3.1 Hospitals and Health Systems
2.3.2 Research Institute
2.3.3 Other
2.3.4 NGS Tumor Gene Analysis Software Market Size by Application
2.3.4.1 NGS Tumor Gene Analysis Software Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
3 NGS TUMOR GENE ANALYSIS SOFTWARE MARKET SIZE BY PLAYER
3.1 NGS Tumor Gene Analysis Software Market Size Market Share by Player
3.1.1 Global NGS Tumor Gene Analysis Software Revenue by Player (2021-2026)
3.1.2 Global NGS Tumor Gene Analysis Software Revenue Market Share by Player (2021-2026)
3.2 Global NGS Tumor Gene Analysis Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NGS TUMOR GENE ANALYSIS SOFTWARE BY REGION
4.1 NGS Tumor Gene Analysis Software Market Size by Region (2021-2026)
4.2 Global NGS Tumor Gene Analysis Software Annual Revenue by Country/Region (2021-2026)
4.3 Americas NGS Tumor Gene Analysis Software Market Size Growth (2021-2026)
4.4 APAC NGS Tumor Gene Analysis Software Market Size Growth (2021-2026)
4.5 Europe NGS Tumor Gene Analysis Software Market Size Growth (2021-2026)
4.6 Middle East & Africa NGS Tumor Gene Analysis Software Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
5.2 Americas NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
5.3 Americas NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NGS Tumor Gene Analysis Software Market Size by Region (2021-2026)
6.2 APAC NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
6.3 APAC NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
7.2 Europe NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
7.3 Europe NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NGS Tumor Gene Analysis Software by Region (2021-2026)
8.2 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
8.3 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NGS TUMOR GENE ANALYSIS SOFTWARE MARKET FORECAST
10.1 Global NGS Tumor Gene Analysis Software Forecast by Region (2027-2032)
10.1.1 Global NGS Tumor Gene Analysis Software Forecast by Region (2027-2032)
10.1.2 Americas NGS Tumor Gene Analysis Software Forecast
10.1.3 APAC NGS Tumor Gene Analysis Software Forecast
10.1.4 Europe NGS Tumor Gene Analysis Software Forecast
10.1.5 Middle East & Africa NGS Tumor Gene Analysis Software Forecast
10.2 Americas NGS Tumor Gene Analysis Software Forecast by Country (2027-2032)
10.2.1 United States Market NGS Tumor Gene Analysis Software Forecast
10.2.2 Canada Market NGS Tumor Gene Analysis Software Forecast
10.2.3 Mexico Market NGS Tumor Gene Analysis Software Forecast
10.2.4 Brazil Market NGS Tumor Gene Analysis Software Forecast
10.3 APAC NGS Tumor Gene Analysis Software Forecast by Region (2027-2032)
10.3.1 China NGS Tumor Gene Analysis Software Market Forecast
10.3.2 Japan Market NGS Tumor Gene Analysis Software Forecast
10.3.3 Korea Market NGS Tumor Gene Analysis Software Forecast
10.3.4 Southeast Asia Market NGS Tumor Gene Analysis Software Forecast
10.3.5 India Market NGS Tumor Gene Analysis Software Forecast
10.3.6 Australia Market NGS Tumor Gene Analysis Software Forecast
10.4 Europe NGS Tumor Gene Analysis Software Forecast by Country (2027-2032)
10.4.1 Germany Market NGS Tumor Gene Analysis Software Forecast
10.4.2 France Market NGS Tumor Gene Analysis Software Forecast
10.4.3 UK Market NGS Tumor Gene Analysis Software Forecast
10.4.4 Italy Market NGS Tumor Gene Analysis Software Forecast
10.4.5 Russia Market NGS Tumor Gene Analysis Software Forecast
10.5 Middle East & Africa NGS Tumor Gene Analysis Software Forecast by Region (2027-2032)
10.5.1 Egypt Market NGS Tumor Gene Analysis Software Forecast
10.5.2 South Africa Market NGS Tumor Gene Analysis Software Forecast
10.5.3 Israel Market NGS Tumor Gene Analysis Software Forecast
10.5.4 Turkey Market NGS Tumor Gene Analysis Software Forecast
10.6 Global NGS Tumor Gene Analysis Software Forecast by Type (2027-2032)
10.7 Global NGS Tumor Gene Analysis Software Forecast by Application (2027-2032)
10.7.1 GCC Countries Market NGS Tumor Gene Analysis Software Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche NGS Tumor Gene Analysis Software Product Offered
11.1.3 Roche NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina NGS Tumor Gene Analysis Software Product Offered
11.2.3 Illumina NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product Offered
11.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 BGI Group
11.4.1 BGI Group Company Information
11.4.2 BGI Group NGS Tumor Gene Analysis Software Product Offered
11.4.3 BGI Group NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BGI Group Main Business Overview
11.4.5 BGI Group Latest Developments
11.5 Novogene
11.5.1 Novogene Company Information
11.5.2 Novogene NGS Tumor Gene Analysis Software Product Offered
11.5.3 Novogene NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Novogene Main Business Overview
11.5.5 Novogene Latest Developments
11.6 Geneseeq
11.6.1 Geneseeq Company Information
11.6.2 Geneseeq NGS Tumor Gene Analysis Software Product Offered
11.6.3 Geneseeq NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Geneseeq Main Business Overview
11.6.5 Geneseeq Latest Developments
11.7 AmoyDx
11.7.1 AmoyDx Company Information
11.7.2 AmoyDx NGS Tumor Gene Analysis Software Product Offered
11.7.3 AmoyDx NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AmoyDx Main Business Overview
11.7.5 AmoyDx Latest Developments
11.8 Burning Rock Medicine
11.8.1 Burning Rock Medicine Company Information
11.8.2 Burning Rock Medicine NGS Tumor Gene Analysis Software Product Offered
11.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Burning Rock Medicine Main Business Overview
11.8.5 Burning Rock Medicine Latest Developments
11.9 GTH.O
11.9.1 GTH.O Company Information
11.9.2 GTH.O NGS Tumor Gene Analysis Software Product Offered
11.9.3 GTH.O NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 GTH.O Main Business Overview
11.9.5 GTH.O Latest Developments
11.10 Golden Helix, Inc
11.10.1 Golden Helix, Inc Company Information
11.10.2 Golden Helix, Inc NGS Tumor Gene Analysis Software Product Offered
11.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Golden Helix, Inc Main Business Overview
11.10.5 Golden Helix, Inc Latest Developments
11.11 Diatech Pharmacogenetics
11.11.1 Diatech Pharmacogenetics Company Information
11.11.2 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product Offered
11.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Diatech Pharmacogenetics Main Business Overview
11.11.5 Diatech Pharmacogenetics Latest Developments
11.12 ViennaLab Diagnostics GmbH
11.12.1 ViennaLab Diagnostics GmbH Company Information
11.12.2 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product Offered
11.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 ViennaLab Diagnostics GmbH Main Business Overview
11.12.5 ViennaLab Diagnostics GmbH Latest Developments
11.13 3D Medicines
11.13.1 3D Medicines Company Information
11.13.2 3D Medicines NGS Tumor Gene Analysis Software Product Offered
11.13.3 3D Medicines NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 3D Medicines Main Business Overview
11.13.5 3D Medicines Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NGS Tumor Gene Analysis Software Market Size (2021-2032)
2.1.2 NGS Tumor Gene Analysis Software Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for NGS Tumor Gene Analysis Software by Country/Region (2021, 2025 & 2032)
2.2 NGS Tumor Gene Analysis Software Segment by Type
2.2.1 Non-Small Cell Lung Cancer
2.2.2 Human 6 Gene Mutations
2.2.3 Human 12 Gene Mutations
2.2.4 Other
2.2.5 NGS Tumor Gene Analysis Software Market Size by Type
2.2.5.1 NGS Tumor Gene Analysis Software Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
2.3 NGS Tumor Gene Analysis Software Segment by Application
2.3.1 Hospitals and Health Systems
2.3.2 Research Institute
2.3.3 Other
2.3.4 NGS Tumor Gene Analysis Software Market Size by Application
2.3.4.1 NGS Tumor Gene Analysis Software Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
3 NGS TUMOR GENE ANALYSIS SOFTWARE MARKET SIZE BY PLAYER
3.1 NGS Tumor Gene Analysis Software Market Size Market Share by Player
3.1.1 Global NGS Tumor Gene Analysis Software Revenue by Player (2021-2026)
3.1.2 Global NGS Tumor Gene Analysis Software Revenue Market Share by Player (2021-2026)
3.2 Global NGS Tumor Gene Analysis Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NGS TUMOR GENE ANALYSIS SOFTWARE BY REGION
4.1 NGS Tumor Gene Analysis Software Market Size by Region (2021-2026)
4.2 Global NGS Tumor Gene Analysis Software Annual Revenue by Country/Region (2021-2026)
4.3 Americas NGS Tumor Gene Analysis Software Market Size Growth (2021-2026)
4.4 APAC NGS Tumor Gene Analysis Software Market Size Growth (2021-2026)
4.5 Europe NGS Tumor Gene Analysis Software Market Size Growth (2021-2026)
4.6 Middle East & Africa NGS Tumor Gene Analysis Software Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
5.2 Americas NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
5.3 Americas NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NGS Tumor Gene Analysis Software Market Size by Region (2021-2026)
6.2 APAC NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
6.3 APAC NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
7.2 Europe NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
7.3 Europe NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NGS Tumor Gene Analysis Software by Region (2021-2026)
8.2 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
8.3 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NGS TUMOR GENE ANALYSIS SOFTWARE MARKET FORECAST
10.1 Global NGS Tumor Gene Analysis Software Forecast by Region (2027-2032)
10.1.1 Global NGS Tumor Gene Analysis Software Forecast by Region (2027-2032)
10.1.2 Americas NGS Tumor Gene Analysis Software Forecast
10.1.3 APAC NGS Tumor Gene Analysis Software Forecast
10.1.4 Europe NGS Tumor Gene Analysis Software Forecast
10.1.5 Middle East & Africa NGS Tumor Gene Analysis Software Forecast
10.2 Americas NGS Tumor Gene Analysis Software Forecast by Country (2027-2032)
10.2.1 United States Market NGS Tumor Gene Analysis Software Forecast
10.2.2 Canada Market NGS Tumor Gene Analysis Software Forecast
10.2.3 Mexico Market NGS Tumor Gene Analysis Software Forecast
10.2.4 Brazil Market NGS Tumor Gene Analysis Software Forecast
10.3 APAC NGS Tumor Gene Analysis Software Forecast by Region (2027-2032)
10.3.1 China NGS Tumor Gene Analysis Software Market Forecast
10.3.2 Japan Market NGS Tumor Gene Analysis Software Forecast
10.3.3 Korea Market NGS Tumor Gene Analysis Software Forecast
10.3.4 Southeast Asia Market NGS Tumor Gene Analysis Software Forecast
10.3.5 India Market NGS Tumor Gene Analysis Software Forecast
10.3.6 Australia Market NGS Tumor Gene Analysis Software Forecast
10.4 Europe NGS Tumor Gene Analysis Software Forecast by Country (2027-2032)
10.4.1 Germany Market NGS Tumor Gene Analysis Software Forecast
10.4.2 France Market NGS Tumor Gene Analysis Software Forecast
10.4.3 UK Market NGS Tumor Gene Analysis Software Forecast
10.4.4 Italy Market NGS Tumor Gene Analysis Software Forecast
10.4.5 Russia Market NGS Tumor Gene Analysis Software Forecast
10.5 Middle East & Africa NGS Tumor Gene Analysis Software Forecast by Region (2027-2032)
10.5.1 Egypt Market NGS Tumor Gene Analysis Software Forecast
10.5.2 South Africa Market NGS Tumor Gene Analysis Software Forecast
10.5.3 Israel Market NGS Tumor Gene Analysis Software Forecast
10.5.4 Turkey Market NGS Tumor Gene Analysis Software Forecast
10.6 Global NGS Tumor Gene Analysis Software Forecast by Type (2027-2032)
10.7 Global NGS Tumor Gene Analysis Software Forecast by Application (2027-2032)
10.7.1 GCC Countries Market NGS Tumor Gene Analysis Software Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche NGS Tumor Gene Analysis Software Product Offered
11.1.3 Roche NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina NGS Tumor Gene Analysis Software Product Offered
11.2.3 Illumina NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product Offered
11.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 BGI Group
11.4.1 BGI Group Company Information
11.4.2 BGI Group NGS Tumor Gene Analysis Software Product Offered
11.4.3 BGI Group NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BGI Group Main Business Overview
11.4.5 BGI Group Latest Developments
11.5 Novogene
11.5.1 Novogene Company Information
11.5.2 Novogene NGS Tumor Gene Analysis Software Product Offered
11.5.3 Novogene NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Novogene Main Business Overview
11.5.5 Novogene Latest Developments
11.6 Geneseeq
11.6.1 Geneseeq Company Information
11.6.2 Geneseeq NGS Tumor Gene Analysis Software Product Offered
11.6.3 Geneseeq NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Geneseeq Main Business Overview
11.6.5 Geneseeq Latest Developments
11.7 AmoyDx
11.7.1 AmoyDx Company Information
11.7.2 AmoyDx NGS Tumor Gene Analysis Software Product Offered
11.7.3 AmoyDx NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AmoyDx Main Business Overview
11.7.5 AmoyDx Latest Developments
11.8 Burning Rock Medicine
11.8.1 Burning Rock Medicine Company Information
11.8.2 Burning Rock Medicine NGS Tumor Gene Analysis Software Product Offered
11.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Burning Rock Medicine Main Business Overview
11.8.5 Burning Rock Medicine Latest Developments
11.9 GTH.O
11.9.1 GTH.O Company Information
11.9.2 GTH.O NGS Tumor Gene Analysis Software Product Offered
11.9.3 GTH.O NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 GTH.O Main Business Overview
11.9.5 GTH.O Latest Developments
11.10 Golden Helix, Inc
11.10.1 Golden Helix, Inc Company Information
11.10.2 Golden Helix, Inc NGS Tumor Gene Analysis Software Product Offered
11.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Golden Helix, Inc Main Business Overview
11.10.5 Golden Helix, Inc Latest Developments
11.11 Diatech Pharmacogenetics
11.11.1 Diatech Pharmacogenetics Company Information
11.11.2 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product Offered
11.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Diatech Pharmacogenetics Main Business Overview
11.11.5 Diatech Pharmacogenetics Latest Developments
11.12 ViennaLab Diagnostics GmbH
11.12.1 ViennaLab Diagnostics GmbH Company Information
11.12.2 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product Offered
11.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 ViennaLab Diagnostics GmbH Main Business Overview
11.12.5 ViennaLab Diagnostics GmbH Latest Developments
11.13 3D Medicines
11.13.1 3D Medicines Company Information
11.13.2 3D Medicines NGS Tumor Gene Analysis Software Product Offered
11.13.3 3D Medicines NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 3D Medicines Main Business Overview
11.13.5 3D Medicines Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. NGS Tumor Gene Analysis Software Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. NGS Tumor Gene Analysis Software Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Small Cell Lung Cancer
Table 4. Major Players of Human 6 Gene Mutations
Table 5. Major Players of Human 12 Gene Mutations
Table 6. Major Players of Other
Table 7. NGS Tumor Gene Analysis Software Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 9. Global NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Table 10. NGS Tumor Gene Analysis Software Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 12. Global NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Table 13. Global NGS Tumor Gene Analysis Software Revenue by Player (2021-2026) & ($ millions)
Table 14. Global NGS Tumor Gene Analysis Software Revenue Market Share by Player (2021-2026)
Table 15. NGS Tumor Gene Analysis Software Key Players Head office and Products Offered
Table 16. NGS Tumor Gene Analysis Software Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global NGS Tumor Gene Analysis Software Market Size by Region (2021-2026) & ($ millions)
Table 20. Global NGS Tumor Gene Analysis Software Market Size Market Share by Region (2021-2026)
Table 21. Global NGS Tumor Gene Analysis Software Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global NGS Tumor Gene Analysis Software Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas NGS Tumor Gene Analysis Software Market Size Market Share by Country (2021-2026)
Table 25. Americas NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Table 27. Americas NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Table 29. APAC NGS Tumor Gene Analysis Software Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC NGS Tumor Gene Analysis Software Market Size Market Share by Region (2021-2026)
Table 31. APAC NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe NGS Tumor Gene Analysis Software Market Size Market Share by Country (2021-2026)
Table 35. Europe NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of NGS Tumor Gene Analysis Software
Table 41. Key Market Challenges & Risks of NGS Tumor Gene Analysis Software
Table 42. Key Industry Trends of NGS Tumor Gene Analysis Software
Table 43. Global NGS Tumor Gene Analysis Software Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global NGS Tumor Gene Analysis Software Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global NGS Tumor Gene Analysis Software Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global NGS Tumor Gene Analysis Software Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Roche Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 48. Roche NGS Tumor Gene Analysis Software Product Offered
Table 49. Roche NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Roche Main Business
Table 51. Roche Latest Developments
Table 52. Illumina Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 53. Illumina NGS Tumor Gene Analysis Software Product Offered
Table 54. Illumina NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Illumina Main Business
Table 56. Illumina Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 58. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product Offered
Table 59. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Thermo Fisher Scientific Main Business
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. BGI Group Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 63. BGI Group NGS Tumor Gene Analysis Software Product Offered
Table 64. BGI Group NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. BGI Group Main Business
Table 66. BGI Group Latest Developments
Table 67. Novogene Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 68. Novogene NGS Tumor Gene Analysis Software Product Offered
Table 69. Novogene NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Novogene Main Business
Table 71. Novogene Latest Developments
Table 72. Geneseeq Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 73. Geneseeq NGS Tumor Gene Analysis Software Product Offered
Table 74. Geneseeq NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Geneseeq Main Business
Table 76. Geneseeq Latest Developments
Table 77. AmoyDx Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 78. AmoyDx NGS Tumor Gene Analysis Software Product Offered
Table 79. AmoyDx NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. AmoyDx Main Business
Table 81. AmoyDx Latest Developments
Table 82. Burning Rock Medicine Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 83. Burning Rock Medicine NGS Tumor Gene Analysis Software Product Offered
Table 84. Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Burning Rock Medicine Main Business
Table 86. Burning Rock Medicine Latest Developments
Table 87. GTH.O Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 88. GTH.O NGS Tumor Gene Analysis Software Product Offered
Table 89. GTH.O NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. GTH.O Main Business
Table 91. GTH.O Latest Developments
Table 92. Golden Helix, Inc Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 93. Golden Helix, Inc NGS Tumor Gene Analysis Software Product Offered
Table 94. Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Golden Helix, Inc Main Business
Table 96. Golden Helix, Inc Latest Developments
Table 97. Diatech Pharmacogenetics Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 98. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product Offered
Table 99. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Diatech Pharmacogenetics Main Business
Table 101. Diatech Pharmacogenetics Latest Developments
Table 102. ViennaLab Diagnostics GmbH Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 103. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product Offered
Table 104. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. ViennaLab Diagnostics GmbH Main Business
Table 106. ViennaLab Diagnostics GmbH Latest Developments
Table 107. 3D Medicines Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 108. 3D Medicines NGS Tumor Gene Analysis Software Product Offered
Table 109. 3D Medicines NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. 3D Medicines Main Business
Table 111. 3D Medicines Latest Developments
Table 1. NGS Tumor Gene Analysis Software Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. NGS Tumor Gene Analysis Software Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Small Cell Lung Cancer
Table 4. Major Players of Human 6 Gene Mutations
Table 5. Major Players of Human 12 Gene Mutations
Table 6. Major Players of Other
Table 7. NGS Tumor Gene Analysis Software Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 9. Global NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Table 10. NGS Tumor Gene Analysis Software Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 12. Global NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Table 13. Global NGS Tumor Gene Analysis Software Revenue by Player (2021-2026) & ($ millions)
Table 14. Global NGS Tumor Gene Analysis Software Revenue Market Share by Player (2021-2026)
Table 15. NGS Tumor Gene Analysis Software Key Players Head office and Products Offered
Table 16. NGS Tumor Gene Analysis Software Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global NGS Tumor Gene Analysis Software Market Size by Region (2021-2026) & ($ millions)
Table 20. Global NGS Tumor Gene Analysis Software Market Size Market Share by Region (2021-2026)
Table 21. Global NGS Tumor Gene Analysis Software Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global NGS Tumor Gene Analysis Software Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas NGS Tumor Gene Analysis Software Market Size Market Share by Country (2021-2026)
Table 25. Americas NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Table 27. Americas NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Table 29. APAC NGS Tumor Gene Analysis Software Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC NGS Tumor Gene Analysis Software Market Size Market Share by Region (2021-2026)
Table 31. APAC NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe NGS Tumor Gene Analysis Software Market Size Market Share by Country (2021-2026)
Table 35. Europe NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of NGS Tumor Gene Analysis Software
Table 41. Key Market Challenges & Risks of NGS Tumor Gene Analysis Software
Table 42. Key Industry Trends of NGS Tumor Gene Analysis Software
Table 43. Global NGS Tumor Gene Analysis Software Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global NGS Tumor Gene Analysis Software Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global NGS Tumor Gene Analysis Software Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global NGS Tumor Gene Analysis Software Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Roche Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 48. Roche NGS Tumor Gene Analysis Software Product Offered
Table 49. Roche NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Roche Main Business
Table 51. Roche Latest Developments
Table 52. Illumina Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 53. Illumina NGS Tumor Gene Analysis Software Product Offered
Table 54. Illumina NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Illumina Main Business
Table 56. Illumina Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 58. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product Offered
Table 59. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Thermo Fisher Scientific Main Business
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. BGI Group Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 63. BGI Group NGS Tumor Gene Analysis Software Product Offered
Table 64. BGI Group NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. BGI Group Main Business
Table 66. BGI Group Latest Developments
Table 67. Novogene Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 68. Novogene NGS Tumor Gene Analysis Software Product Offered
Table 69. Novogene NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Novogene Main Business
Table 71. Novogene Latest Developments
Table 72. Geneseeq Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 73. Geneseeq NGS Tumor Gene Analysis Software Product Offered
Table 74. Geneseeq NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Geneseeq Main Business
Table 76. Geneseeq Latest Developments
Table 77. AmoyDx Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 78. AmoyDx NGS Tumor Gene Analysis Software Product Offered
Table 79. AmoyDx NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. AmoyDx Main Business
Table 81. AmoyDx Latest Developments
Table 82. Burning Rock Medicine Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 83. Burning Rock Medicine NGS Tumor Gene Analysis Software Product Offered
Table 84. Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Burning Rock Medicine Main Business
Table 86. Burning Rock Medicine Latest Developments
Table 87. GTH.O Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 88. GTH.O NGS Tumor Gene Analysis Software Product Offered
Table 89. GTH.O NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. GTH.O Main Business
Table 91. GTH.O Latest Developments
Table 92. Golden Helix, Inc Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 93. Golden Helix, Inc NGS Tumor Gene Analysis Software Product Offered
Table 94. Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Golden Helix, Inc Main Business
Table 96. Golden Helix, Inc Latest Developments
Table 97. Diatech Pharmacogenetics Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 98. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product Offered
Table 99. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Diatech Pharmacogenetics Main Business
Table 101. Diatech Pharmacogenetics Latest Developments
Table 102. ViennaLab Diagnostics GmbH Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 103. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product Offered
Table 104. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. ViennaLab Diagnostics GmbH Main Business
Table 106. ViennaLab Diagnostics GmbH Latest Developments
Table 107. 3D Medicines Details, Company Type, NGS Tumor Gene Analysis Software Area Served and Its Competitors
Table 108. 3D Medicines NGS Tumor Gene Analysis Software Product Offered
Table 109. 3D Medicines NGS Tumor Gene Analysis Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. 3D Medicines Main Business
Table 111. 3D Medicines Latest Developments
LIST OF FIGURES
Figure 1. NGS Tumor Gene Analysis Software Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NGS Tumor Gene Analysis Software Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. NGS Tumor Gene Analysis Software Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. NGS Tumor Gene Analysis Software Sales Market Share by Country/Region (2025)
Figure 8. NGS Tumor Gene Analysis Software Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global NGS Tumor Gene Analysis Software Market Size Market Share by Type in 2025
Figure 10. NGS Tumor Gene Analysis Software in Hospitals and Health Systems
Figure 11. Global NGS Tumor Gene Analysis Software Market: Hospitals and Health Systems (2021-2026) & ($ millions)
Figure 12. NGS Tumor Gene Analysis Software in Research Institute
Figure 13. Global NGS Tumor Gene Analysis Software Market: Research Institute (2021-2026) & ($ millions)
Figure 14. NGS Tumor Gene Analysis Software in Other
Figure 15. Global NGS Tumor Gene Analysis Software Market: Other (2021-2026) & ($ millions)
Figure 16. Global NGS Tumor Gene Analysis Software Market Size Market Share by Application in 2025
Figure 17. Global NGS Tumor Gene Analysis Software Revenue Market Share by Player in 2025
Figure 18. Global NGS Tumor Gene Analysis Software Market Size Market Share by Region (2021-2026)
Figure 19. Americas NGS Tumor Gene Analysis Software Market Size 2021-2026 ($ millions)
Figure 20. APAC NGS Tumor Gene Analysis Software Market Size 2021-2026 ($ millions)
Figure 21. Europe NGS Tumor Gene Analysis Software Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa NGS Tumor Gene Analysis Software Market Size 2021-2026 ($ millions)
Figure 23. Americas NGS Tumor Gene Analysis Software Value Market Share by Country in 2025
Figure 24. United States NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC NGS Tumor Gene Analysis Software Market Size Market Share by Region in 2025
Figure 29. APAC NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Figure 30. APAC NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Figure 31. China NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 35. India NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe NGS Tumor Gene Analysis Software Market Size Market Share by Country in 2025
Figure 38. Europe NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Figure 39. Europe NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Figure 40. Germany NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 41. France NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 42. UK NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa NGS Tumor Gene Analysis Software Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Figure 48. Egypt NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 54. APAC NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 55. Europe NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 57. United States NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 58. Canada NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 59. Mexico NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 60. Brazil NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 61. China NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 62. Japan NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 63. Korea NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 65. India NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 66. Australia NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 67. Germany NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 68. France NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 69. UK NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 70. Italy NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 71. Russia NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 72. Egypt NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 73. South Africa NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 74. Israel NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 75. Turkey NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 76. Global NGS Tumor Gene Analysis Software Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global NGS Tumor Gene Analysis Software Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 1. NGS Tumor Gene Analysis Software Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NGS Tumor Gene Analysis Software Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. NGS Tumor Gene Analysis Software Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. NGS Tumor Gene Analysis Software Sales Market Share by Country/Region (2025)
Figure 8. NGS Tumor Gene Analysis Software Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global NGS Tumor Gene Analysis Software Market Size Market Share by Type in 2025
Figure 10. NGS Tumor Gene Analysis Software in Hospitals and Health Systems
Figure 11. Global NGS Tumor Gene Analysis Software Market: Hospitals and Health Systems (2021-2026) & ($ millions)
Figure 12. NGS Tumor Gene Analysis Software in Research Institute
Figure 13. Global NGS Tumor Gene Analysis Software Market: Research Institute (2021-2026) & ($ millions)
Figure 14. NGS Tumor Gene Analysis Software in Other
Figure 15. Global NGS Tumor Gene Analysis Software Market: Other (2021-2026) & ($ millions)
Figure 16. Global NGS Tumor Gene Analysis Software Market Size Market Share by Application in 2025
Figure 17. Global NGS Tumor Gene Analysis Software Revenue Market Share by Player in 2025
Figure 18. Global NGS Tumor Gene Analysis Software Market Size Market Share by Region (2021-2026)
Figure 19. Americas NGS Tumor Gene Analysis Software Market Size 2021-2026 ($ millions)
Figure 20. APAC NGS Tumor Gene Analysis Software Market Size 2021-2026 ($ millions)
Figure 21. Europe NGS Tumor Gene Analysis Software Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa NGS Tumor Gene Analysis Software Market Size 2021-2026 ($ millions)
Figure 23. Americas NGS Tumor Gene Analysis Software Value Market Share by Country in 2025
Figure 24. United States NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC NGS Tumor Gene Analysis Software Market Size Market Share by Region in 2025
Figure 29. APAC NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Figure 30. APAC NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Figure 31. China NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 35. India NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe NGS Tumor Gene Analysis Software Market Size Market Share by Country in 2025
Figure 38. Europe NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Figure 39. Europe NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Figure 40. Germany NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 41. France NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 42. UK NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa NGS Tumor Gene Analysis Software Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa NGS Tumor Gene Analysis Software Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa NGS Tumor Gene Analysis Software Market Size Market Share by Application (2021-2026)
Figure 48. Egypt NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries NGS Tumor Gene Analysis Software Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 54. APAC NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 55. Europe NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 57. United States NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 58. Canada NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 59. Mexico NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 60. Brazil NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 61. China NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 62. Japan NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 63. Korea NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 65. India NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 66. Australia NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 67. Germany NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 68. France NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 69. UK NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 70. Italy NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 71. Russia NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 72. Egypt NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 73. South Africa NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 74. Israel NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 75. Turkey NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
Figure 76. Global NGS Tumor Gene Analysis Software Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global NGS Tumor Gene Analysis Software Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries NGS Tumor Gene Analysis Software Market Size 2027-2032 ($ millions)
